Sterigenics, a subsidiary of Sotera Health and a specialist in comprehensive sterilisation services, has expanded its ethylene oxide (EO) facility located in Rantigny, France to increase European sterilisation capacity.
The expansion increases the Rantigny facility's total sterilisation throughput and diversifies its capabilities with the addition of a 32-pallet chamber.
"Local and regional demand for contract sterilisation services has been increasing to meet healthcare needs," said Pontus Rundstrom, VP of Operations EMEAA. "The additional capacity at Rantigny shows our commitment to our sterilisation customers by helping to get their products into the market in a fast, flexible and reliable way."
The Sterigenics' Rantigny facility provides routine EO, EOStat rapid processing, cycle development and process validation and offers laboratory testing services through its co-located Nelson Labs facility.
The Rantigny expansion follows Sterigenics' recent acquisition of Iotron Industries, a leading electron beam provider in North America. The acquisition further expands the company's capacity across multiple technologies throughout its global network.